Merck & Co.

MRKleader

Merck is a global pharmaceutical giant anchored by Keytruda, the world's best-selling drug, with strong franchises in oncology, vaccines, and animal health.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($60.1B)

Datos estáticos (cargando finanzas en tiempo real…)

Oncology (45%)

Vaccines (18%)

Hospital & Specialty (14%)

Animal Health (12%)

Other Pharma (11%)

Composición de segmentos y clientes principales

Detalles del producto

Keytruda42%

World's top-selling drug — PD-1 immune checkpoint inhibitor for oncology

Gardasil / Vaccines14%

HPV vaccine and other prophylactic vaccines

Lagevrio & Antivirals8%

COVID-19 antiviral and legacy antiviral portfolio

Animal Health (Organon split)10%

Livestock and companion animal vaccines and pharmaceuticals

Relaciones en la Cadena de Suministro

Competidores

Pfizer Inc.

Oncology and vaccines

Impacto: High — direct competitor in multiple therapeutic areas

Eli Lilly and Company

Oncology pipeline

Impacto: Medium — growing oncology rival

Clientes Clave

Walgreens Boots Alliance

Prescription drug retail

Impacto: Medium — pharmacy distribution channel

Socios

Organon & Co.

Legacy women's health portfolio spin-off

Impacto: Low — Organon spin-off relationship

Contexto macro y de mercado

제약 / 바이오Noticias del sector

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

Próximos catalizadores

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de Merck & Co. impulsado por IA.

Información de la Empresa

Sede Central

Rahway, New Jersey, USA

Fundación

1891

Empleados

69,000+

Sitio Web

merck.com

Estado del sector — 제약 / 바이오

Noticias del sector